{"id":7653,"date":"2026-10-14T17:31:43","date_gmt":"2026-10-14T15:31:43","guid":{"rendered":"https:\/\/maraz.es\/?p=7653"},"modified":"2026-10-14T20:25:50","modified_gmt":"2026-10-14T18:25:50","slug":"goodwill-valuation-and-impairment","status":"publish","type":"post","link":"https:\/\/maraz.es\/en\/goodwill-valuation-and-impairment\/","title":{"rendered":"Goodwill: what it is, how it is valued, when it is impaired and how it is taxed in Spain"},"content":{"rendered":"<h2>Why goodwill matters<\/h2>\n<p><strong>When one company buys another, it almost never pays exactly what the balance sheet says: it pays for the customer base, the brand, the team, the market position and the synergies it expects to capture. The difference between the price paid and the fair value of what is acquired is goodwill.<\/strong><\/p>\n<p>In the Spanish middle market it is usually one of the largest items on the balance sheet after an acquisition, and the most contested: it determines how much profit amortisation consumes each year, constrains dividend distributions, creates differences between accounting and taxable profit and, if the acquired business underperforms, forces an impairment that can wipe out several years of results. Understanding how goodwill is defined, valued and impaired is an essential part of <a href=\"https:\/\/maraz.es\/en\/financial-advisory\/\">financial advisory for companies<\/a> in any corporate transaction, and all the more so in Spain, where the Spanish General Accounting Plan (PGC) governs individual accounts and most consolidated accounts, while International Financial Reporting Standards (IFRS\/IAS) apply to listed groups.<\/p>\n<h2>What goodwill is<\/h2>\n<p><strong>Goodwill is the excess of the cost of a business combination over the fair value of the identifiable assets acquired less the liabilities assumed. By definition it is a residual: what is left of the price once everything that can be identified and measured separately has been allocated.<\/strong><\/p>\n<p><strong>From an economic standpoint, that residual captures elements that generate value but do not qualify for recognition as separate assets:<\/strong> the going concern itself, the trained and cohesive workforce, reputation, informal relationships with customers and suppliers, and the synergies the buyer expects to obtain. It may also include, although nobody admits it in the notes to the accounts, the premium paid in a competitive negotiation.<\/p>\n<p><strong>Classical financial theory puts it another way: goodwill is the present value of excess earnings, that is, of the return the business generates above what would normally be required on its identifiable net assets. This definition underpins the valuation methods discussed below.<\/strong><\/p>\n<h3>Acquired goodwill versus internally generated goodwill<\/h3>\n<p><strong>Both the PGC (recognition and measurement standards NRV 5 and 6) and IAS 38 prohibit the recognition of internally generated goodwill:<\/strong> a company that has spent thirty years building its brand and customer base cannot capitalise that value, because it is not an identifiable resource with a reliably measurable cost. Only when a third party pays for it in a business combination does it become an accounting asset.<\/p>\n<h3>Accounting nature<\/h3>\n<p><strong>Under the PGC, goodwill is an intangible fixed asset (account 204) that can only be recognised if it was acquired for consideration in a business combination;<\/strong> under IFRS it is presented as a separate line item with its own regime.<\/p>\n<p>In consolidated accounts, goodwill arises from the difference between the cost of the investment and the proportional share of the subsidiary\u2019s net assets at fair value (Royal Decree 1159\/2010).<\/p>\n<h2>How goodwill is valued before the deal<\/h2>\n<p><strong>Before any accounting goodwill exists, a price has to be agreed, and that price embeds an implicit estimate of what the items missing from the balance sheet are worth. In the pre-deal phase, <a href=\"https:\/\/maraz.es\/en\/business-valuation-sale\/\">business valuation<\/a> offers two families of methods for quantifying it: those that derive it from the overall value of the company and those that calculate it directly from excess earnings.<\/strong><\/p>\n<h3>Implied goodwill: discounted cash flow and multiples<\/h3>\n<p>The dominant approach in corporate finance first obtains the <a href=\"https:\/\/maraz.es\/en\/enterprise-value-vs-equity-value-key-differences\/\">enterprise value<\/a> (EV) by discounting free cash flows (FCF) at the weighted average cost of capital (WACC), plus a terminal value (TV) based on a perpetual growth rate (g); implied goodwill is the difference between that enterprise value and the net substantial value (NSV), that is, the identifiable net assets at fair value:<\/p>\n<p><strong>EV = \u03a3 FCF<sub>t<\/sub> \/ (1 + WACC)<sup>t<\/sup> + TV \/ (1 + WACC)<sup>n<\/sup><\/strong>, where <strong>TV = FCF<sub>n+1<\/sub> \/ (WACC \u2212 g)<\/strong><\/p>\n<p><strong>Goodwill = EV \u2212 NSV<\/strong><\/p>\n<p>With <a href=\"https:\/\/maraz.es\/en\/how-to-interpret-ev-ebitda\/\">market multiples<\/a> the reasoning is identical: EV = multiple \u00d7 EBITDA and Goodwill = EV \u2212 NSV. The advantage of both methods is their alignment with international practice; their limitation is sensitivity to the WACC, the growth rate g and the comparables chosen. One percentage point of WACC can move implied goodwill by more than 15%.<\/p>\n<h3>Mixed excess-earnings methods<\/h3>\n<p><strong>The mixed methods, long established in European practice and still common in <a href=\"https:\/\/maraz.es\/en\/financial-report-forensic\/\">expert witness reports<\/a>, family business valuations and negotiations between shareholders, start from the substantial value (NSV) and add the present value of excess earnings:<\/strong> the difference between expected normalised profit (B) and normal profit (k \u00d7 NSV), where k is the return the market would require on those assets. The excess earnings are capitalised at a rate i higher than k, because the persistence of an unidentified intangible is more uncertain than that of a tangible asset.<\/p>\n<p><strong>Anglo-Saxon or direct method.<\/strong> Capitalises excess earnings in perpetuity:<\/p>\n<p><strong>Goodwill = (B \u2212 k \u00d7 NSV) \/ i<\/strong><\/p>\n<p><strong>German or indirect method.<\/strong> Takes as enterprise value the average of the substantial value and the earnings value (EarV = B \/ k), which splits goodwill equally between buyer and seller:<\/p>\n<p><strong>EV = (NSV + EarV) \/ 2, hence Goodwill = (EarV \u2212 NSV) \/ 2<\/strong><\/p>\n<p><strong>Union of European Accountants (UEC) method.<\/strong> Corrects the previous ones by requiring that the normal return k also be applied to goodwill itself (EV = NSV + Goodwill):<\/p>\n<p><strong>Goodwill = (B \u2212 k \u00d7 NSV) \/ (i + k)<\/strong><\/p>\n<h3>From valuation to PPA: the cross-check that reveals overpayment<\/h3>\n<p><strong>In the post-closing PPA, identifiable intangibles are valued with their own methods (relief-from-royalty for brands, multi-period excess earnings or MPEEM for customer relationships) and goodwill is left as the residual.<\/strong> Best practice requires a reconciliation: the IRR implied by the price must be consistent with the WACC and with the weighted average return on the assets acquired (WARA), goodwill included. If the only way to make the numbers add up is to require a disproportionate return on goodwill, the price embeds buyer-specific synergies or, quite simply, an overpayment, and it is far cheaper to detect that before signing than to impair it two years later.<\/p>\n<h2>How goodwill arises: the acquisition method and the PPA<\/h2>\n<p><strong>Goodwill arises on the acquisition date of a business combination, applying the acquisition method set out in NRV 19 of the PGC and in IFRS 3. The process has four steps:<\/strong><\/p>\n<ol>\n<li><strong>Identify the acquirer, the party that obtains control.<\/strong><\/li>\n<li><strong>Determine the acquisition date<\/strong>, the date on which control becomes effective.<\/li>\n<li><strong>Determine the cost of the combination:<\/strong> the fair value of the consideration transferred (cash, shares, debt assumed) plus contingent consideration such as earn-outs. Transaction costs (lawyers, advisers, due diligence) are expensed.<\/li>\n<li><strong>Recognise at fair value the identifiable assets acquired and liabilities assumed<\/strong>, including those the seller had not recorded.<\/li>\n<\/ol>\n<p><strong>Goodwill is the positive difference between step 3 and step 4.<\/strong> If the difference is negative (badwill), the standard requires a reassessment of the identification and measurement of all items and, once confirmed, recognition as a gain in profit or loss.<\/p>\n<h3>The purchase price allocation exercise (PPA)<\/h3>\n<p><strong>Step 4 is what really determines the size of goodwill and is known as the PPA: identifying and valuing the intangibles the target did not carry on its balance sheet but which meet the identifiability criterion (brands, customer relationships, technology, patents, licences, favourable contracts, order backlog, non-compete agreements).<\/strong><\/p>\n<p><em>Note: the allocation is not neutral. Identified intangibles are amortised over periods that are normally shorter than goodwill, which accelerates the accounting charge in the early years. A rigorous, documented PPA that can be defended before the auditor prevents goodwill from absorbing value that belongs in identifiable line items.<\/em><\/p>\n<h2>Subsequent measurement under the PGC: amortisation over ten years<\/h2>\n<p><strong>Since 1 January 2016, following Royal Decree 602\/2016 (which transposed Directive 2013\/34\/EU), the PGC requires goodwill to be amortised. NRV 6 presumes, unless there is evidence to the contrary, a useful life of ten years with straight-line recovery;<\/strong> in practice almost every company applies 10% per year, and anyone estimating a different useful life must justify it in the notes.<\/p>\n<p>This was a reversal of the 2008\u20132015 model, which had no amortisation and a mandatory annual impairment test as under IFRS, and was driven by the European preference for prudence. The transitional provision allowed pre-existing goodwill to be amortised either prospectively from 2016 or retrospectively against reserves, an election that still shapes the amortisation profile of many earlier acquisitions.<\/p>\n<h3>Impairment under the PGC<\/h3>\n<p><strong>Amortisation does not exempt goodwill from impairment. NRV 2 and NRV 6 require companies to check for indicators of a loss in value and, where they exist, to estimate the recoverable amount of the cash-generating unit to which goodwill was allocated. Since 2016 the test is no longer annual but indicator-driven.<\/strong><\/p>\n<p>The ICAC Resolution of 18 September 2013 on the impairment of assets sets out the procedure (indicators, CGUs, value in use, fair value less costs of disposal, allocation of the loss and disclosures), and the Resolution of 28 May 2013 on intangible assets completes the regime. Both remain the reference, with the adjustments introduced by the 2016 reform.<\/p>\n<p><strong>One essential difference: impairment losses on goodwill are never reversed in subsequent years, even if the causes that gave rise to them disappear.<\/strong><\/p>\n<h2>Subsequent measurement under IFRS: no amortisation, annual test<\/h2>\n<p><strong>The international model is the opposite. Since 2004, with IFRS 3 and the revision of IAS 36, goodwill is not amortised: it is assigned an indefinite useful life, and straight-line amortisation is considered arbitrary because it does not reflect how the associated economic benefits are actually consumed.<\/strong><\/p>\n<p><strong>In exchange, IAS 36 requires an impairment test at least once a year, at the same date each year, and whenever there is an indicator.<\/strong> Goodwill is allocated from the acquisition date to the cash-generating units (CGUs) or groups of CGUs expected to benefit from the synergies, at a level no higher than an operating segment under IFRS 8.<\/p>\n<p>In practice, a group reporting under IFRS carries goodwill at its original amount for as long as the CGUs keep generating sufficient value. This flatters earnings, which bear no amortisation charge, but shifts the risk: when impairment comes, it tends to be sudden and large.<\/p>\n<p>The debate is not over. The IASB spent years considering whether to reintroduce amortisation and, in its project Business Combinations \u2014 Disclosures, Goodwill and Impairment (exposure draft of March 2024, redeliberated in 2025 and 2026), decided to retain the impairment-only model and to focus the changes on better disclosure of acquisition performance. The FASB reached the same conclusion after abandoning its own amortisation project in 2022.<\/p>\n<h2>The impairment test step by step<\/h2>\n<p><strong>The mechanics are the same under IAS 36 and under the 2013 ICAC Resolution, which is modelled on it. What changes is the frequency (annual under IFRS, indicator-driven under the PGC) and the base (gross amount under IFRS, net of amortisation under the PGC).<\/strong><\/p>\n<h3>1. Identify indicators<\/h3>\n<p>Indicators may be external (a fall in market value, adverse changes in the legal, technological or competitive environment, rising interest rates that push up the discount rate, market capitalisation below book equity) or internal (obsolescence, restructuring, performance below plan, loss of key customers). In a recent acquisition, the most common indicator is that the business is not delivering the plan on which the price was set.<\/p>\n<h3>2. Define the cash-generating unit<\/h3>\n<p>Goodwill does not generate cash flows on its own, so it is never tested in isolation: it is allocated to the smallest CGU with independent cash inflows, and the recoverable amount of that unit is compared with its carrying amount, goodwill included. A CGU drawn too widely can mask the impairment of a specific business by offsetting it against more profitable ones.<\/p>\n<h3>3. Calculate the recoverable amount<\/h3>\n<p>The recoverable amount is the higher of two figures:<\/p>\n<ul>\n<li><strong>Fair value less costs of disposal:<\/strong> the price obtainable in an orderly transaction between market participants, less the direct costs of sale; it is estimated using comparable transaction multiples, quoted prices or a market-participant DCF.<\/li>\n<li><strong>Value in use:<\/strong> the present value of the CGU\u2019s future cash flows, based on budgets approved by management (normally five years) plus a terminal value, excluding uncommitted restructurings and improvements arising from investments not yet made.<\/li>\n<\/ul>\n<p>The discount rate must be pre-tax and reflect the time value of money and the specific risks not already adjusted for in the cash flows; in practice it starts from the WACC of comparable companies, adjusted for size, country and specific risk. A common error is to mix post-tax cash flows with pre-tax rates.<\/p>\n<h3>4. Allocate the loss, with no subsequent reversal<\/h3>\n<p>If the carrying amount of the CGU exceeds its recoverable amount, the difference is allocated first to the goodwill assigned to the unit and, once that is exhausted, to the remaining assets of the unit pro rata, without reducing any of them below its own recoverable amount. Neither IAS 36 nor the PGC allows a goodwill impairment to be reversed later, so that any recovery does not reflect internally generated goodwill; impairment of the CGU\u2019s other assets can be reversed.<\/p>\n<h2>PGC, IFRS and LIS: the differences that matter<\/h2>\n<table width=\"100%\">\n<thead>\n<tr>\n<td>\n<p style=\"text-align: center;\"><strong>Aspect<\/strong><\/p>\n<\/td>\n<td style=\"text-align: center;\"><strong>PGC (Royal Decree 1514\/2007, as amended by RD 602\/2016)<\/strong><\/td>\n<td style=\"text-align: center;\"><strong>IFRS (IFRS 3 and IAS 36)<\/strong><\/td>\n<td style=\"text-align: center;\"><strong>LIS (Spanish Corporate Income Tax Act 27\/2014)<\/strong><\/td>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>\n<p style=\"text-align: center;\"><strong>Nature<\/strong><\/p>\n<\/td>\n<td style=\"text-align: center;\">Intangible with a finite useful life<\/td>\n<td style=\"text-align: center;\">Asset with an indefinite useful life<\/td>\n<td style=\"text-align: center;\">Intangible deductible from the tax base<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center;\"><strong>Initial recognition<\/strong><\/td>\n<td style=\"text-align: center;\">Acquisition method, NRV 19<\/td>\n<td style=\"text-align: center;\">Acquisition method, IFRS 3<\/td>\n<td>\n<p style=\"text-align: center;\">Only if recorded in the individual accounts and acquired for consideration<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p style=\"text-align: center;\"><strong>Amortisation<\/strong><\/p>\n<\/td>\n<td style=\"text-align: center;\">Yes, presumed useful life of 10 years, straight-line<\/td>\n<td style=\"text-align: center;\">Not amortised<\/td>\n<td style=\"text-align: center;\">Deductible at 5% per year (art. 12.2), regardless of accounting treatment<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center;\"><strong>Period<\/strong><\/td>\n<td style=\"text-align: center;\">10 years<\/td>\n<td style=\"text-align: center;\">Indefinite<\/td>\n<td>\n<p style=\"text-align: center;\">20 years<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p style=\"text-align: center;\"><strong>Impairment test<\/strong><\/p>\n<\/td>\n<td style=\"text-align: center;\">When indicators exist, on the net carrying amount<\/td>\n<td style=\"text-align: center;\">Mandatory annual test, on the gross amount<\/td>\n<td style=\"text-align: center;\">Impairment not deductible (art. 13.2)<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center;\"><strong>Reversal of impairment<\/strong><\/td>\n<td style=\"text-align: center;\">Prohibited<\/td>\n<td style=\"text-align: center;\">Prohibited<\/td>\n<td>\n<p style=\"text-align: center;\">Not applicable<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p style=\"text-align: center;\"><strong>Negative goodwill (badwill)<\/strong><\/p>\n<\/td>\n<td style=\"text-align: center;\">Gain in profit or loss after reassessment<\/td>\n<td style=\"text-align: center;\">Gain in profit or loss after reassessment<\/td>\n<td style=\"text-align: center;\">Included in the tax base<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center;\"><strong>Deferred tax<\/strong><\/td>\n<td style=\"text-align: center;\">Deferred tax asset (10% amortisation vs 5% deduction)<\/td>\n<td style=\"text-align: center;\">Deferred tax liability (deduction with no charge)<\/td>\n<td>\n<p style=\"text-align: center;\">Source of the temporary difference<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center;\"><strong>Interpretative guidance<\/strong><\/td>\n<td style=\"text-align: center;\">ICAC Resolutions of 28 May and 18 September 2013; BOICAC rulings<\/td>\n<td style=\"text-align: center;\">IAS 36, IAS 38, IFRS IC decisions<\/td>\n<td>\n<p style=\"text-align: center;\">DGT binding rulings; transitional provision 27 of the LIS<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<h2>The tax treatment of goodwill in Spain<\/h2>\n<p><strong>The Spanish Corporate Income Tax Act (Law 27\/2014, LIS) follows its own path, independent of both the PGC and IFRS, and it shapes the structure of the deal, the seller\u2019s tax bill and the buyer\u2019s post-tax return.<\/strong><\/p>\n<h3>Deductibility of amortisation: 5% per year<\/h3>\n<p><strong>Article 12.2 of the LIS allows goodwill to be deducted up to an annual limit of one twentieth of its amount (5% over twenty years), irrespective of its accounting treatment: the deduction is the same whether goodwill is amortised at 10% (PGC) or not amortised at all (IFRS). <\/strong>Between 2012 and 2015 the limit was temporarily cut to 1%, which still affects the balance outstanding on acquisitions made in those years.<\/p>\n<p><strong>The deduction requires that goodwill was acquired for consideration and is recorded in the taxpayer\u2019s individual accounts, which only happens when the business itself is bought<\/strong> (assets or a line of business) or when the acquired company is subsequently merged and the merger difference surfaces.<\/p>\n<h3>Impairment is not deductible<\/h3>\n<p><strong>Article 13.2 of the LIS makes impairment losses on intangible assets, goodwill included, non-deductible<\/strong>. An accounting impairment does not reduce the tax base; the outstanding amount continues to be deducted at 5% per year on the original value, and the temporary difference gives rise to a deferred tax asset.<\/p>\n<h3>Deferred tax: how accounting and tax fit together<\/h3>\n<p><strong>The gap between the accounting charge and the tax deduction means deferred tax must be recognised in every scenario:<\/strong><\/p>\n<ul>\n<li><strong>Under the PGC<\/strong>, accounting amortisation at 10% is double the 5% deduction: half the charge is not deductible in the year and builds up a growing deferred tax asset over the first decade. Between years eleven and twenty the adjustment turns negative and the asset unwinds until it disappears.<\/li>\n<li><strong>Under IFRS<\/strong>, the 5% deduction with no accounting charge creates a growing deferred tax liability; the IAS 12 exemption covers the initial recognition of goodwill, not the differences that arise afterwards.<\/li>\n<li><strong>A non-deductible impairment<\/strong> generates a deferred tax asset whose recoverability must be assessed with the same prudence as any other tax credit.<\/li>\n<\/ul>\n<h3>Share deal versus asset deal: the asymmetry that structures transactions<\/h3>\n<p>In a share deal the buyer records a financial investment, not goodwill; goodwill only surfaces on consolidation and is not deductible, nor, since 2013, is any impairment of the shareholding (articles 13.2 and 15.k of the LIS).<\/p>\n<p>In an asset deal the buyer obtains a stepped-up tax base and deducts goodwill at 5% per year, but the seller is taxed on the gain on each asset at the standard corporate income tax rate, with no exemption.<\/p>\n<p>A sale of shares, by contrast, allows a corporate seller to apply the article 21 LIS exemption on 95% of the gain (shareholding of at least 5% held for more than one year), giving an effective tax rate of around 1.25%; if the seller is an individual, the gain is taxed within the savings base of personal income tax.<\/p>\n<p>This asymmetry explains why the vast majority of Spanish middle-market transactions close as share deals: the seller\u2019s tax saving far exceeds the present value of the deduction the buyer forgoes, and it ends up reflected in the price. In family businesses there is the further consideration that the wealth tax exemption and the 95% inheritance and gift tax relief apply to the shares. Quantifying the lost deduction is a legitimate argument for the buyer in the negotiation.<\/p>\n<h3>Subsequent merger and the merger difference<\/h3>\n<p>An intermediate route is to buy the shares and then merge the acquired company under the tax-neutral regime (Chapter VII of Title VII of the LIS), allocating the merger difference first to the assets and the remainder to goodwill. Until 2014, article 89.3 of the former consolidated Corporate Income Tax Act allowed that goodwill to be deducted provided the shares had been bought from unrelated third parties and the seller had been taxed on the gain; the 2015 LIS removed the deduction for shares acquired from 1 January 2015 onwards, preserving it only for earlier acquisitions (transitional provision 27). A subsequent merger therefore no longer makes the goodwill on a recent acquisition deductible.<\/p>\n<h2>Practical implications in an M&amp;A transaction<\/h2>\n<p><strong>Before closing.<\/strong> Under the PGC, goodwill of \u20ac5 million means \u20ac500,000 of amortisation a year for ten years, of which only \u20ac250,000 is deductible. That charge can turn a cash-accretive acquisition into a source of accounting losses, with consequences for dividends, covenants and minority shareholders. A preliminary PPA during <a href=\"https:\/\/maraz.es\/en\/financial-due-diligence\/\">financial due diligence<\/a> quantifies it, along with the effect of earn-outs, which increase initial goodwill, and documents the business plan supporting the price, because that plan will be the basis of the future impairment test.<\/p>\n<p><strong>After closing.<\/strong> Allocate goodwill to the CGUs from day one and track the acquired business against plan. Sustained negative deviations are the clearest indicator of impairment and the one recognised latest; a late, large impairment damages credibility with auditors, lenders and the market far more than an early, well-explained adjustment.<\/p>\n<p><strong>In the family business.<\/strong> Goodwill is usually financed with bank debt whose <a href=\"https:\/\/maraz.es\/en\/financial-covenants-how-to-negotiate-them-with-banks\/\">covenants<\/a> are calculated on accounting figures. It is worth negotiating from the outset that ratios are measured on EBITDA and net debt, not on net profit or equity, so that amortisation does not trigger technical breaches in an otherwise healthy transaction.<\/p>\n<h2>Conclusion<\/h2>\n<p><strong>Goodwill sums up how much a company has paid for what cannot be touched or counted: customers, people, reputation and expectations. Its treatment depends on the framework<\/strong> (ten-year amortisation with indicator-driven impairment under the PGC; no amortisation but an annual test under IFRS; a 5% deduction and non-deductible impairment under the LIS), but all of them demand the same thing: a prior valuation cross-checked by more than one method, a rigorous PPA, a clear allocation to CGUs and honest monitoring of the acquired business against the plan that justified the price.<\/p>\n<p>Anticipating goodwill and its accounting, tax and financial effects before closing spares the buyer surprises and helps the seller explain and negotiate the price. For both, an <a href=\"https:\/\/maraz.es\/en\/mergers-acquisitions\/\">M&amp;A adviser<\/a> who commands valuation, accounting and tax makes the difference between an acquisition that enhances the balance sheet and one that weighs on it for a decade.<\/p>\n<p><strong>At Maraz Corporate Finance we support family and middle-market businesses in valuing, buying and selling companies, in purchase price allocation and in defending goodwill before auditors, lenders and shareholders. If you are considering an acquisition or want to know how it will affect your accounts and your tax bill, <a href=\"https:\/\/maraz.es\/en\/contact\/\">contact our team<\/a>.<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"http:\/\/www.linkedin.com\/in\/javierderojas\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #333399;\"><strong>Javier de Rojas Roca de Togores<\/strong><\/span><\/a><\/p>\n<p><span style=\"color: #333399;\"><strong>Partner &#8211; Maraz Corporate Finance<\/strong><\/span><\/p>\n<p>&nbsp;<\/p>\n<h2><em>FAQs on goodwill<\/em><\/h2>\n<h3><em>What is the difference between goodwill and other intangible assets?<\/em><\/h3>\n<p><em>An identifiable intangible asset (brand, customer list, patent, software, contract) can be separated from the business and sold or licensed on its own, or arises from a contractual or legal right, and for that reason it is recognised and amortised individually. Goodwill is what remains of the price once all those intangibles have been identified and valued: the going concern, the workforce, reputation and synergies. The better the purchase price allocation, the more value shifts to identifiable intangibles and the smaller the residual goodwill, which changes the amortisation profile and the impairment risk of the whole acquisition.<\/em><\/p>\n<h3><em>Is goodwill amortised in Spain?<\/em><\/h3>\n<p><em>It depends on the accounting framework. Under the Spanish General Accounting Plan, yes: since 2016 it is amortised over a presumed ten-year life (10% a year) and is also impaired if indicators exist. Under IFRS it is not amortised, but it is subject to an annual impairment test. For tax purposes, the Corporate Income Tax Act allows a 5% annual deduction regardless of the accounting treatment, which creates deferred tax under both frameworks.<\/em><\/p>\n<h3><em>When must the impairment test be performed, and who should carry it out?<\/em><\/h3>\n<p><em>Under IFRS, at least once a year at the same date and whenever an indicator appears; under the PGC, when indicators exist, such as the acquired business performing below plan, the loss of key customers, rising interest rates or adverse changes in the sector. The test compares the carrying amount of the cash-generating unit with its recoverable amount and requires projections, a defensible discount rate and a sensitivity analysis. The finance function prepares it, but in significant transactions it is advisable to rely on an independent <\/em><a href=\"https:\/\/maraz.es\/en\/business-valuation-sale\/\"><em>business valuation<\/em><\/a><em> that will withstand the auditor\u2019s review.<\/em><\/p>\n<h3><em>Is goodwill tax-deductible?<\/em><\/h3>\n<p><em>Yes, within limits. Article 12.2 of the Corporate Income Tax Act allows up to one twentieth (5%) of goodwill acquired for consideration and recorded in the individual accounts to be deducted each year, irrespective of its accounting amortisation. Impairment, however, is not deductible (article 13.2). And in a share purchase goodwill only surfaces on consolidation and is not deductible, so the structure of the deal (share deal versus asset deal) determines whether the buyer can benefit from the deduction.<\/em><\/p>\n<h3><em>How does goodwill affect the sale price of my company?<\/em><\/h3>\n<p><em>For the seller, goodwill is the part of the price the buyer pays above the fair value of the net assets, that is, for the customer base, the team, the brand and growth expectations. <\/em><\/p>\n<p><em>The more recurring and well-documented the EBITDA, the stronger the customer base and the clearer the competitive advantage, the more goodwill a buyer will be willing to pay. But the buyer will also anticipate the amortisation and impairment that goodwill will generate and will factor it into the negotiation. Preparing the company with a vendor due diligence and a credible business plan is the best way to defend that value in a <\/em><a href=\"https:\/\/maraz.es\/en\/mergers-acquisitions\/\"><em>sale process<\/em><\/a><em>.<\/em><\/p>\n<h3><em>What is negative goodwill or badwill?<\/em><\/h3>\n<p><em>It arises when the fair value of the net assets acquired exceeds the price paid, which happens in bargain purchases: sellers under pressure, loss-making businesses or businesses in restructuring, or undervalued assets. Both the PGC and IFRS 3 require a reassessment of the identification and measurement of all assets and liabilities first, because badwill usually hides an unrecognised liability or an overvalued asset. If confirmed, it is recognised as a gain in the profit and loss account of the acquisition year and is taxed accordingly. The <\/em><a href=\"https:\/\/maraz.es\/en\/success-and-failure-in-mergers-and-acquisitions\/\"><em>keys to success in M&amp;A<\/em><\/a><em> lie precisely in a due diligence that detects these situations before signing.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Why goodwill matters When one company buys another, it almost never pays exactly what the balance sheet says: it pays for the customer base, the brand, the team, the market position and the synergies it expects to capture. The difference between the price paid and the fair value of what is acquired is goodwill. In [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":7654,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[162],"tags":[],"class_list":["post-7653","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-financial-advisory"],"acf":{"team_member_autor":{"ID":1417,"post_author":"3","post_date":"2025-03-17 16:11:58","post_date_gmt":"2025-03-17 15:11:58","post_content":"","post_title":"Javier de Rojas Roca de Togores","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"javier-de-rojas-roca-de-togores","to_ping":"","pinged":"","post_modified":"2026-10-07 13:24:42","post_modified_gmt":"2026-10-07 11:24:42","post_content_filtered":"","post_parent":0,"guid":"https:\/\/maraz.es\/?post_type=team_member&#038;p=1417","menu_order":0,"post_type":"team_member","post_mime_type":"","comment_count":"0","filter":"raw"}},"_links":{"self":[{"href":"https:\/\/maraz.es\/en\/wp-json\/wp\/v2\/posts\/7653","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/maraz.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/maraz.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/maraz.es\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/maraz.es\/en\/wp-json\/wp\/v2\/comments?post=7653"}],"version-history":[{"count":1,"href":"https:\/\/maraz.es\/en\/wp-json\/wp\/v2\/posts\/7653\/revisions"}],"predecessor-version":[{"id":7655,"href":"https:\/\/maraz.es\/en\/wp-json\/wp\/v2\/posts\/7653\/revisions\/7655"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/maraz.es\/en\/wp-json\/wp\/v2\/media\/7654"}],"wp:attachment":[{"href":"https:\/\/maraz.es\/en\/wp-json\/wp\/v2\/media?parent=7653"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/maraz.es\/en\/wp-json\/wp\/v2\/categories?post=7653"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/maraz.es\/en\/wp-json\/wp\/v2\/tags?post=7653"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}